2018
DOI: 10.1053/j.semperi.2018.09.004
|View full text |Cite
|
Sign up to set email alerts
|

Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
35
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 49 publications
(36 citation statements)
references
References 53 publications
0
35
0
1
Order By: Relevance
“…Microbial data were obtained during routine weekly screening and can therefore be easily adopted by the clinics to early on identify infants at special risk and to delineate therapeutic interventions with the aim to restore the physiologic situation of bacterial colonization. As the preterm infant is exposed to non-physiologic bacteria from the surrounding NICU [ 41 , 42 ] in a situation where the immune system is immature and incapable of bacterial clearance, its insufficient defense mechanisms might account for the highly significant result which is surprising taking into account the multifactorial origins of BPD [ 43 , 44 ].…”
Section: Discussionmentioning
confidence: 99%
“…Microbial data were obtained during routine weekly screening and can therefore be easily adopted by the clinics to early on identify infants at special risk and to delineate therapeutic interventions with the aim to restore the physiologic situation of bacterial colonization. As the preterm infant is exposed to non-physiologic bacteria from the surrounding NICU [ 41 , 42 ] in a situation where the immune system is immature and incapable of bacterial clearance, its insufficient defense mechanisms might account for the highly significant result which is surprising taking into account the multifactorial origins of BPD [ 43 , 44 ].…”
Section: Discussionmentioning
confidence: 99%
“…In the field of genomics, various approaches including integrated genomic analysis 40 and gene expression profiling 41 have led to the identification of novel pathways of lung development and repair (the cell-surface glycoprotein CD44, phosphorus oxygen lyase activity) and novel molecules and pathways (adenosine deaminase, targets of microRNA [miR]) that are associated with the genetic origins of BPD 42 . In addition to whole exome sequencing and whole genome sequencing to identify non-common variants in patients with BPD, RNA sequencing methods have been developed to evaluate protein-coding mRNA, transcripts of pseudogenes, long non-coding RNA (lncRNA), and miRs 43 . In the last few years, miRs have been described as important mediators of normal growth, development, and disease.…”
Section: Diagnosis and Assessmentmentioning
confidence: 99%
“…Although potential candidates are reported, identifying BPD specific genes, pathways, single nucleotide polymorphisms, long noncoding RNAs, or microRNAs has not proven easy. 11,12 Yet, great hope persists that identifying genetic factors in the development of BPD could lead to specific therapies. Providers could then tailor interventions to individual patients to improve outcomes, minimize risk, and lower costs.…”
Section: Geneticsmentioning
confidence: 99%